Showing 1,268 results

Filters Content type: News, Editors' picks Topic: New & experimental HIV treatments

News and information about clinical trials and regulatory approval of new medications to treat HIV.

New & experimental HIV treatments

Sugar-binding protein may play a role in HIV infection

Editor's pick
Science Daily
11 August 2011
New & experimental HIV treatments

U.S. Food and Drug Administration Approves Gilead Science's Complera

Editor's pick
Drugs.com
11 August 2011
New & experimental HIV treatments

Scientist develops virus that targets HIV: Using a virus to kill a virus

Editor's pick
Moreover.com HIV/AIDS feed
8 August 2011
New & experimental HIV treatments

Vacc-4x Reduces Viral Load in HIV Patients Off ART

Editor's pick
Medscape (requires registration)
26 July 2011
Pregnancy and vertical transmission

Valaciclovir slows HIV disease progression in pregnant and breastfeeding women

News
26 July 2011
Sexually transmitted infections tests & treatment

Herpes drugs and viral load: valaciclovir works better than aciclovir

News
26 July 2011
New & experimental HIV treatments

New integrase inhibitor dolutegravir looks potent and well-tolerated

News
26 July 2011
New & experimental HIV treatments

Another NRTI-sparing regimen does well in treatment-naive patients

News
25 July 2011
New & experimental HIV treatments

New NNRTI lersivirine matches efavirenz in phase 2 study

News
22 July 2011
New & experimental HIV treatments

AIDS: No hiding place

Editor's pick
The Economist
22 July 2011
New & experimental HIV treatments

Once-daily elvitegravir matches raltegravir

News
21 July 2011
Starting treatment

HIV treatment in primary infection: 48 week course modestly delays CD4 drop

News
20 July 2011
Bone & joint problems

Raltegravir combined with Kaletra associated with good preservation of bone density over 96 weeks

News
19 July 2011
New & experimental HIV treatments

Daily aciclovir slows HIV disease progression and reduces viral load

News
19 July 2011
New & experimental HIV treatments

Abbott Confirms Long-Term Commitment to HIV Care with the Planned Development ... - istockAnalyst.com (press release)

Editor's pick
Abbott
15 July 2011
New & experimental HIV treatments

HIV, Hep C Drug Development Pipeline is 'Robust,' Says Report

Editor's pick
Poz magazine news
15 July 2011
Pharmaceutical industry

Gilead Licence Expands Access, But Several Countries Left Out

Editor's pick
MSF
12 July 2011
Pharmaceutical industry

Gilead licenses four HIV drugs to Medicines Patent Pool

Editor's pick
Medicines Patent Pool
12 July 2011
Pharmaceutical industry

Gilead kickstarts patent pool for AIDS drugs

Editor's pick
Reuters
12 July 2011
New & experimental HIV treatments

Gladstone Institute to receive $5.6 million in federal funds to seek a cure for AIDS

Editor's pick
Eurekalert Medicine & Health
11 July 2011
New & experimental HIV treatments

Merck, Sangamo to Gain From $70 Million Boost in AIDS Cure Hunt

Editor's pick
Bloomberg
11 July 2011
New & experimental HIV treatments

NIH funds new research toward an HIV cure

Editor's pick
Eurekalert Medicine & Health
11 July 2011
Exposure to HIV through medical procedures

Hemophilia is Target of Therapy on Genome

Editor's pick
New York Times
27 June 2011
New & experimental HIV treatments

Tobira Therapeutics Inc. Initiates Phase IIb Trial of Cenicriviroc, a Novel CCR5/CCR2 Antagonist for the Treatment of HIV Infection

Editor's pick
Tobira
22 June 2011